Skip to content
ESOM20

Drawing based on the label description. No photo yet.

“Esomeprazole magnesium delayed-release capsules, USP 20 mg - Light yellow to brown colored enteric coated pellets filled in size "4" hard gelatin capsule, opaque dark blue cap & opaque dark blue body printed "ESOM" on cap and "20" on the body in white ink”

ESOM 20 pill

Pill with imprint ESOM 20 is blue, capsule, 14 mm and has been identified as Esomeprazole Magnesium Delayed Release Capsules 20 mg. It is supplied by Nucare Pharmaceuticals,inc.

Esomeprazole Magnesium Delayed Release Capsules 20 mg

Imprint
ESOM 20
Strength
20 mg
Color
Blue
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Capsule, coated pellets
Manufacturer
Nucare Pharmaceuticals,inc
NDC
68071-2922, 67877-571, 68071-2922-6, 71335-9678, 71335-9678-1, 71335-9678-2, 71335-9678-3, 71335-9678-4, 71335-9678-5, 71335-9678-6, 71335-9678-7, 71335-9678-8, 76420-226, 76420-226-30, 76420-226-60, 76420-226-90, 71205-706, 71205-706-30, 71205-706-60, 71205-706-90, 67877-571-30, 67877-571-05, 67877-571-10, 67877-571-38, 67877-571-90

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Esomeprazole Magnesium Delayed Release Capsules pills and guides

What is Esomeprazole Magnesium Delayed Release Capsules used for?

Official uses from the US prescribing label

Healing of Erosive Esophagitis (EE)

Adults

Esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed EE in adults. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4- to 8-week course of esomeprazole magnesium may be considered.

Pediatric Patients

12 Years to 17 Years of Age

Esomeprazole magnesium delayed-release capsules indicated for the short-term treatment (4 to 8 weeks) for the healing of EE in pediatric patients 12 years to 17 years of age.

Maintenance of Healing of EE

Esomeprazole magnesium delayed-release capsules are indicated for the maintenance of healing of EE in adults. Controlled studies do not extend beyond 6 months.

Treatment of Symptomatic GERD

Adults

Esomeprazole magnesium delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with GERD in adults.

Pediatric Patients 12 Years to 17 Years of Age

Esomeprazole magnesium delayed-release capsules are indicated for short-term treatment (4 weeks) of heartburn and other symptoms associated with GERD in pediatric patients 12 years to 17 years of age.

Risk Reduction of Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Associated Gastric Ulcer

Esomeprazole magnesium delayed-release capsules are indicated for the reduction in the occurrence of gastric ulcers associated with continuous NSAID therapy in adult patients at risk for developing gastric ulcers. Patients are considered to be at risk due to their age (60 years and older) and/or documented history of gastric ulcers. Controlled studies do not extend beyond 6 months.

Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence

Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Triple Therapy

Esomeprazole magnesium delayed-release capsules in combination with amoxicillin and clarithromycin is indicated for the treatment of adult patients with H. pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate H. pylori.

In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted.

Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome

Esomeprazole magnesium delayed-release capsules are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome, in adults.

From the FDA-approved label on DailyMed (published Jun 13, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows ESOM 20. The parts can be split between the two sides, so turn the pill over and check both.
  • It is blue, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Esomeprazole Magnesium.

Ingredients

Active: Esomeprazole Magnesium

Inactive: Silicon Dioxide, Hypromellose, Unspecified, Magnesium Stearate, Meglumine, Methacrylic Acid and Ethyl Acrylate Copolymer, Glyceryl Mono and Dicaprylocaprate, Poloxamer 188, Talc, Triethyl Citrate, Gelatin, Unspecified, Fd&c Blue No. 1, Titanium Dioxide, Sodium Lauryl Sulfate, Potassium Hydroxide, Shellac, Fd&c Red No. 40, Sucrose

Also distributed by

Bryant Ranch Prepack, Asclemed Usa, Inc., Proficient Rx LP, Ascend Laboratories, LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Esomeprazole Magnesium Delayed Release Capsules pills